331 related articles for article (PubMed ID: 11930330)
1. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.
Aberg JA; Price RW; Heeren DM; Bredt B
J Infect Dis; 2002 Apr; 185(8):1179-82. PubMed ID: 11930330
[TBL] [Abstract][Full Text] [Related]
2. [Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].
Negroni R; Helou SH; López Daneri G; Robles AM; Arechavala AI; Bianchi MH
Rev Argent Microbiol; 2004; 36(3):113-7. PubMed ID: 15559192
[TBL] [Abstract][Full Text] [Related]
3. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
[TBL] [Abstract][Full Text] [Related]
4. Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy.
Sheng WH; Hung CC; Chen MY; Hsieh SM; Chang SC
Int J STD AIDS; 2002 Oct; 13(10):702-5. PubMed ID: 12396541
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G
AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
Skiest DJ; Hester LJ; Hardy RD
J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
[TBL] [Abstract][Full Text] [Related]
8. Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Rambeloarisoa J; Batisse D; Thiebaut JB; Mikol J; Mrejen S; Karmochkine M; Kazatchkine MD; Weiss L; Piketty C
J Infect; 2002 Apr; 44(3):185-8. PubMed ID: 12099747
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
Sungkanuparph S; Filler SG; Chetchotisakd P; Pappas PG; Nolen TL; Manosuthi W; Anekthananon T; Morris MI; Supparatpinyo K; Kopetskie H; Kendrick AS; Johnson PC; Sobel JD; Larsen RA
Clin Infect Dis; 2009 Sep; 49(6):931-4. PubMed ID: 19681708
[TBL] [Abstract][Full Text] [Related]
10. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.
Lilleri D; Piccinini G; Genini E; Comolli G; Chiesa A; Tordato F; Sotgiu G; Parisi A; Baldanti F; Revello MG; Gerna G
J Clin Virol; 2004 Apr; 29(4):297-307. PubMed ID: 15018859
[TBL] [Abstract][Full Text] [Related]
12. Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole.
Nightingale SD
Arch Intern Med; 1995 Mar; 155(5):538-40. PubMed ID: 7864710
[TBL] [Abstract][Full Text] [Related]
13. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
Goldman M; Zackin R; Fichtenbaum CJ; Skiest DJ; Koletar SL; Hafner R; Wheat LJ; Nyangweso PM; Yiannoutsos CT; Schnizlein-Bick CT; Owens S; Aberg JA;
Clin Infect Dis; 2004 May; 38(10):1485-9. PubMed ID: 15156489
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
15. [Microbiological aspects of the cryptococcosis in the post-HAART era].
Mazuelos EM; García AI
Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():40-5. PubMed ID: 20172422
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
Denning DW; Tucker RM; Hanson LH; Hamilton JR; Stevens DA
Arch Intern Med; 1989 Oct; 149(10):2301-8. PubMed ID: 2552949
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous colesional acquired immunodeficiency syndrome associated Kaposi sarcoma and cryptococcosis.
Ramdial PK; Sing Y; Subrayan S; Calonje E
Am J Dermatopathol; 2010 Dec; 32(8):780-6. PubMed ID: 20802305
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
19. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
[TBL] [Abstract][Full Text] [Related]
20. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
